cardiovirus
includ
encephalomyocard
viru
emcv
human
saffold
viru
small
nonenvelop
virus
belong
picornavirida
larg
famili
positivesens
rna
rna
virus
rna
virus
remodel
intracellular
membran
uniqu
structur
viral
genom
replic
accumul
evid
suggest
picornavirus
differ
genera
use
differ
strategi
gener
viral
replic
organel
ro
instanc
enterovirus
eg
polioviru
coxsackieviru
rhinoviru
reli
golgiloc
phosphatidylinositol
iii
beta
cardiovirus
replic
independ
kinas
mechan
cardiovirus
develop
ro
current
unknown
show
cardiovirus
manipul
anoth
name
erloc
phosphatidylinositol
iii
alpha
gener
ro
sirnamedi
knockdown
pharmacolog
inhibit
demonstr
essenti
host
factor
emcv
genom
replic
reveal
emcv
nonstructur
protein
interact
respons
recruit
viral
ro
ensu
phosphatidylinositol
prove
import
recruit
oxysterolbind
protein
osbp
deliv
cholesterol
emcv
ro
manner
lipid
cholesterol
shown
requir
global
organ
ro
viral
genom
replic
consist
inhibit
osbp
express
function
effici
block
emcv
rna
replic
conclus
describ
first
time
cellular
pathway
involv
biogenesi
cardioviru
ro
remark
pathway
report
promot
format
replic
site
plo
pathogen
organ
scientif
research
nwo
fjmvk
jrpm
hmvd
deutsch
forschungsgemeinschaft
lo
vl
hepat
c
viru
member
flavivirida
famili
picornavirus
flavivirus
thu
result
highlight
converg
recruit
distantli
relat
rna
virus
host
lipidmodifi
pathway
underli
format
viral
replic
site
positivesens
rna
virus
rna
virus
replic
viral
genom
tight
associ
reorgan
membran
structur
virus
gener
uniqu
structur
often
term
replic
organel
ro
effici
manipul
host
lipid
metabol
molecular
mechan
underli
ro
format
enterovirus
eg
polioviru
famili
picornavirida
extens
investig
littl
known
member
belong
larg
famili
studi
provid
first
detail
insight
ro
biogenesi
encephalomyocard
viru
emcv
picornaviru
genu
cardioviru
reveal
emcv
hijack
lipid
kinas
kinas
gener
viral
ro
enrich
phosphatidylinositol
emcvinfect
cell
lipid
play
essenti
role
viru
replic
recruit
anoth
cellular
protein
oxysterolbind
protein
osbp
ro
osbp
impact
lipid
composit
ro
membran
mediat
exchang
cholesterol
membranemodif
mechan
emcv
remark
similar
distantli
relat
flaviviru
hepat
c
viru
hcv
distinct
close
relat
enterovirus
recruit
osbp
via
anoth
name
thu
emcv
hcv
repres
strike
case
function
converg
rna
viru
evolut
univers
mobil
leiden
univers
fund
aeg
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
compet
interest
author
declar
compet
interest
exist
protein
coopt
host
factor
enterovirus
instanc
hijack
member
secretori
pathway
replic
format
ro
among
viral
nonstructur
protein
well
precursor
contain
hydrophob
domain
confer
membranemodifi
properti
consider
interest
given
studi
small
viral
protein
key
viral
player
involv
membran
rearrang
interact
recruit
secretori
pathway
compon
golgispecif
brefeldin
aresist
guanin
nucleotid
exchang
factor
kinas
type
iii
isoform
ro
despit
intens
investig
role
enteroviru
replic
yet
elucid
review
recruit
ro
lead
signific
local
increas
membran
enzymat
product
environ
serv
recruit
essenti
viral
host
factor
replic
site
viral
polymeras
pol
abl
specif
bind
vitro
recent
other
reveal
play
central
role
enteroviru
replic
recruit
oxysterolbind
protein
osbp
ro
uninfect
cell
osbp
bridg
er
golgi
membran
bind
er
integr
membran
protein
vapa
transgolgi
sterolbind
domain
osbp
shuttl
cholesterol
er
golgi
golgi
er
therebi
gener
lipid
counterflow
ergolgi
membran
contact
site
mcss
enteroviru
infect
osbp
exchang
cholesterol
like
erro
mcss
uniqu
lipid
protein
composit
enteroviru
ro
determin
particular
architectur
consist
complex
tubulovesicular
network
shown
cell
infect
pv
coxsackieviru
lipid
transfer
function
osbp
membran
contact
site
vital
enterovirus
also
hcv
hcv
genom
replic
occur
associ
erderiv
network
special
membran
vesicl
call
membran
web
mw
like
enteroviru
ro
hcv
mw
enrich
lipid
cholesterol
case
hcv
gener
recruit
activ
erloc
enzym
kinas
type
iii
isoform
viral
protein
thu
far
inform
regard
virushost
interact
govern
format
cardioviru
ro
remain
scarc
report
zhang
et
al
suggest
autophagi
support
emcv
replic
studi
show
emcv
infect
trigger
accumul
autophagosomelik
vesicl
cytoplasm
emcv
coloc
autophagi
marker
howev
inhibit
autophagi
exert
minor
effect
viru
replic
argu
strong
implic
autophagi
pathway
cardioviru
genom
replic
andor
format
ro
evid
role
autophagi
viru
replic
also
exist
enterovirus
flavivirus
rather
relat
nonlyt
viru
releas
modul
host
innat
immun
respons
viral
genom
replic
base
observ
cardiovirus
requir
replic
gener
believ
cardioviru
replic
strategi
distinct
enterovirus
set
elucid
whether
cardioviru
replic
depend
anoth
isoform
sirnamedi
knockdown
identifi
key
player
replic
emcv
emcv
interact
recruit
ro
increas
local
synthesi
eventu
lead
downstream
recruit
osbp
show
shuttl
activ
osbp
import
global
distribut
ro
viru
genom
replic
data
reveal
exploit
cellular
pathway
cardioviru
replic
strategi
profoundli
resembl
distantli
relat
hcv
dissimilar
character
picornavirus
flavivirus
critic
aspect
thu
similar
emcv
hcv
strike
case
function
converg
picornaviru
emcv
converg
host
lipid
pathway
use
hcv
plo
pathogen
picornavirida
larg
famili
positivesens
rna
virus
rna
virus
compris
mani
clinic
relev
human
anim
pathogen
member
genu
enteroviru
includ
import
human
virus
like
polioviru
pv
caus
agent
poliomyel
coxsackievirus
cv
caus
mening
myocard
rhinovirus
rv
respons
common
cold
exacerb
asthma
chronic
obstruct
pulmonari
diseas
perhap
bestknown
nonhuman
picornaviru
footandmouthdiseas
viru
fmdv
genu
aphtoviru
caus
devast
outbreak
cattl
lead
sever
econom
loss
close
relat
apthoviru
genu
genu
cardioviru
compos
three
speci
theiloviru
tv
encephalomyocard
viru
emcv
recent
discov
boon
cardioviru
speci
theiloviru
includ
among
other
theiler
murin
encephalomyocard
viru
tmev
saffold
viru
safv
human
cardioviru
tmev
known
caus
enter
infect
sometim
sever
enceph
chronic
infect
central
nervou
system
yet
safv
firmli
associ
clinic
diseas
emcv
infect
wide
rang
anim
rodent
consid
natur
reservoir
domest
anim
pig
prone
emcv
infect
lead
fatal
myocard
reproduct
failur
sow
sudden
death
piglet
like
rna
virusessuch
hepat
c
viru
hcv
dengu
viru
denv
chikungunya
viru
chikv
coronaviru
cov
picornavirus
replic
genom
rna
special
virusmodifi
intracellular
membran
remodel
membran
term
replic
organel
ro
aris
concert
action
viral
nonstructur
virushost
interact
indic
divers
rna
virus
might
limit
choic
pathway
remodel
host
membran
network
viru
replic
unlik
enterovirus
cardiovirus
requir
replic
investig
whether
might
involv
cardioviru
replic
deplet
four
distinct
cellular
sirnamedi
gene
knockdown
use
set
sirna
sequenc
ambion
previous
test
effici
toxic
monitor
subsequ
effect
replic
emcv
observ
inhibitori
effect
emcv
replic
silenc
upon
silenc
fig
confirm
import
emcv
replic
perform
anoth
seri
knockdown
experi
use
anoth
set
sirna
sequenc
qiagen
deplet
significantli
reduc
emcv
infect
measur
endpoint
titrat
progeni
viru
product
fig
next
wonder
step
viru
life
cycl
depend
omit
step
viru
attach
cell
entri
emcv
rna
vitro
transcrib
subsequ
transfect
cell
deplet
sirna
viru
replic
strongli
inhibit
upon
silenc
measur
endpoint
titrat
progeni
virion
fig
indic
involv
postentri
step
viru
life
cycl
elucid
whether
emcv
requir
viral
genom
amplif
infect
cell
renilla
luciferaseencod
emcv
rlucemcv
quantifi
luciferas
activ
measur
viral
rna
replic
emcv
rna
replic
sever
impair
cell
lack
fig
exclud
inhibit
emcv
replic
silenc
due
cytotox
effect
cell
viabil
assay
fig
verifi
knockdown
effici
western
blot
analysi
fig
altogeth
result
show
play
key
role
emcv
genom
rna
replic
next
investig
whether
emcv
requir
enzymat
activ
use
inhibitor
also
block
higher
concentr
cell
infect
emcv
rlucemcv
moi
treat
increas
concentr
h
coxsackieviru
well
enterovirus
previous
shown
hijack
golgiloc
replic
includ
control
measur
endpoint
titrat
analysi
luciferas
activ
fig
emcv
replic
effici
inhibit
dosedepend
manner
complet
inhibit
detect
replic
hamper
fig
line
prefer
dipyridamol
wellestablish
inhibitor
emcv
rna
replic
includ
posit
control
importantli
inhibit
emcv
replic
also
infect
perform
high
moi
fig
moi
corrobor
activ
requir
step
viral
genom
replic
perform
timeofaddit
experi
ad
cell
differ
time
point
infect
rlucemcv
similar
dipyridamol
strongli
inhibit
replic
ad
h
infect
fig
indic
entri
rather
step
genom
replic
block
next
test
whether
member
cardioviru
genu
also
depend
replic
similar
emcv
replic
human
cardioviru
saffold
viru
speci
theiloviru
also
sensit
treatment
fig
cell
viabil
assay
demonstr
treatment
exert
slight
cytotox
effect
highest
concentr
test
fig
result
indic
differ
cardioviru
speci
requir
enzymat
activ
genom
replic
soon
infect
cytoplasm
emcvinfect
cell
accumul
impress
amount
vesicular
membran
structur
yet
littl
inform
avail
regard
viral
protein
host
factor
associ
new
virusinduc
organel
set
investig
whether
present
emcv
ro
despit
repeat
effort
unabl
detect
endogen
kinas
immunofluoresc
stain
cell
line
test
altern
chose
analyz
possibl
chang
subcellular
distribut
ectop
express
upon
emcv
infect
mockinfect
cell
fig
upper
panel
distribut
diffus
throughout
entir
cytoplasm
previous
report
other
infect
cell
visual
dsrna
stain
instead
observ
clear
differ
local
kinas
redistribut
discret
cytoplasm
puncta
perinuclear
region
fig
lower
panel
next
aim
elucid
whether
puncta
coincid
viral
ro
small
picornavir
protein
precursor
membraneassoci
play
key
role
viral
rna
replic
recruit
essenti
host
factor
henc
consid
suitabl
marker
emcv
ro
compar
stain
infect
cell
observ
strike
overlap
structur
fig
lower
panel
could
confirm
phenotyp
analyz
local
ectop
express
bear
hatag
fig
contrast
signal
mainli
local
golgi
noninfect
cell
fig
top
panel
fail
overlap
fig
lower
panel
interestingli
although
close
proxim
dsrna
signal
fig
lower
panel
clearli
overlap
dsrna
fig
inset
taken
togeth
data
demonstr
select
recruit
emcv
ro
interestingli
notic
loss
typic
golgi
local
emcvinfect
cell
fig
lower
panel
suggest
golgi
integr
might
affect
upon
emcv
infect
prompt
find
emcv
util
erloc
replic
set
elucid
whether
er
golgi
compon
present
emcv
ro
order
abl
use
antibodi
combin
immunofluoresc
construct
recombin
emcv
bear
hatag
nonstructur
protein
tag
introduc
second
amino
acid
leav
cleavag
site
intact
fig
impair
viru
replic
fig
first
check
whether
present
membran
immunofluoresc
microscopi
inde
signal
greatli
overlap
fig
support
idea
protein
occupi
membran
ro
use
tag
emcv
notic
golgi
structur
inde
alter
infect
cell
h
pi
onward
reveal
dispers
pattern
cisand
transgolgi
marker
fig
respect
fig
howev
neither
present
structur
suggest
emcv
ro
golgideriv
marker
ergolgi
intermedi
compart
also
cell
infect
emcv
ac
rlucemcv
moi
transfect
fulllength
infecti
emcv
vitrotranscrib
rna
c
h
cell
freezethaw
releas
intracellular
viru
particl
total
viru
titer
determin
endpoint
titrat
ac
altern
cell
lyse
renilla
luciferas
activ
determin
measur
viral
rna
replic
parallel
cell
viabil
assay
perform
evalu
cytotox
sirna
treatment
e
f
western
blot
analysi
show
effici
knockdown
actin
use
load
control
gi
treatment
inhibit
cardioviru
replic
hela
cell
infect
viru
moi
g
h
follow
treatment
h
cell
lyse
viru
replic
measur
endpoint
titrat
g
determin
renilla
luciferas
activ
h
cytotox
determin
cell
viabil
assay
run
parallel
j
bar
repres
mean
valu
triplic
standard
error
mean
sem
mean
statist
compar
use
unpair
test
p
p
p
appear
scatter
throughout
cytoplasm
infect
cell
without
overlap
fig
next
compar
local
copiicoatom
complex
compon
er
exit
site
ere
marker
er
marker
calreticulin
noninfect
cell
display
mainli
typic
perinuclear
local
emcvinfect
cell
appear
dispers
without
significantli
coloc
fig
mander
coloc
coeffici
fraction
overlap
observ
greater
degre
overlap
calreticulin
fig
fraction
calreticulin
overlap
imag
acquir
higher
magnif
reveal
close
contact
er
tubul
fig
taken
togeth
data
suggest
emcv
possibl
replic
erderiv
membran
base
extens
overlap
drastic
chang
pattern
infect
cell
hypothes
might
recruit
replic
site
interact
directli
indirectli
one
viral
nonstructur
protein
investig
use
stabl
cell
line
allow
ectop
protein
express
control
promot
previous
optim
valid
reliabl
reproduc
cellular
system
studi
interact
radioact
coip
assay
myctag
emcv
nonstructur
protein
individu
coexpress
togeth
cell
radioact
label
affin
purifi
cell
lysat
use
antimyc
specif
antibodi
autoradiographi
analysi
show
specif
copurifi
viral
protein
fig
confirm
interact
coimmunoprecipit
coip
coupl
western
blot
analysi
myctag
emcv
coexpress
subject
affin
purif
use
either
monoclon
polyclon
antimyc
antibodi
shown
fig
interact
emcv
interact
includ
neg
control
data
impli
emcv
nonstructur
protein
respons
recruit
ro
interestingli
diffus
band
kda
appear
copurifi
emcv
coexpress
fig
indic
reason
could
indic
tempor
regul
activ
infect
via
degrad
explor
possibl
perform
western
blot
analysi
endogen
time
cours
infect
detect
band
indic
degrad
neither
hela
cell
fig
test
alon
recruit
examin
immunofluoresc
subcellular
local
coexpress
consid
neg
control
express
alon
local
throughout
cell
diffus
pattern
fig
top
panel
previous
describ
emcv
local
throughout
cytoplasm
discret
punctat
structur
subset
also
posit
fig
also
distribut
puncta
throughout
cytoplasm
fail
recruit
fig
collect
result
indic
emcv
viral
protein
respons
engag
replic
produc
golgi
membran
respons
synthesi
pool
plasma
membran
dynam
local
find
activ
critic
emcv
rna
replic
prompt
us
investig
whether
metabol
alter
viru
replic
given
emcv
replic
picornaviru
emcv
converg
host
lipid
pathway
use
hcv
intracellular
membran
monitor
potenti
chang
subcellular
distribut
plasma
membran
pm
intracellular
ic
pool
cell
follow
emcv
infect
two
pool
select
visual
use
two
differ
immunocytochemistri
protocol
previous
establish
hammond
et
al
plasma
membran
pool
appear
unaffect
emcvinfect
cell
fig
intracellular
distribut
chang
perinuclear
golgilik
pattern
mockinfect
cell
dispers
throughout
cytoplasm
emcvinfect
cell
fig
observ
similar
phenotyp
hela
cell
fig
indic
observ
effect
cell
linespecif
notabl
quantit
analysi
fluoresc
signal
reveal
mark
increas
level
intracellular
infect
cell
fig
rule
possibl
involv
establish
elev
level
observ
emcv
infect
cell
treat
cell
inhibitor
compound
simultan
detect
viral
ro
immunofluoresc
infect
cell
short
treatment
sever
deplet
golgi
pool
noninfect
cell
fig
thu
reflect
effect
inhibit
activ
howev
phenotyp
remain
unalt
infect
cell
fig
demonstr
emcvinduc
accumul
intracellular
mediat
local
vicin
least
small
subset
overlap
fig
data
togeth
find
emcv
requir
activ
suggest
lipid
play
central
role
emcv
genom
replic
variou
cellular
protein
carri
domain
call
pleckstrinhomolog
domain
ph
ceramidetransf
protein
cert
fourphosphateadaptor
protein
oxysterolbind
protein
osbp
sens
specif
bind
lipid
recent
other
show
enterovirus
gener
membran
recruit
osbp
turn
exchang
cholesterol
ro
moreov
show
emcv
sensit
itraconazol
identifi
osbp
inhibitor
cholesterol
shuttl
import
emcv
replic
therefor
reason
emcvinfect
cell
one
purpos
lipid
might
recruit
osbp
replic
membran
support
viral
rna
replic
test
osbp
requir
emcv
replic
effici
reduc
osbp
express
hela
cell
sirna
gene
silenc
fig
evalu
subsequ
effect
emcv
replic
endpoint
titrat
analysi
replic
emcv
significantli
reduc
cell
osbp
deplet
compar
controltr
cell
fig
indic
osbp
requir
effici
replic
use
osbp
ligand
interfer
normal
osbp
function
pharmacolog
inhibit
osbp
analyz
whether
lipid
transfer
function
link
emcv
infect
use
luciferaseencod
emcv
observ
complet
inhibit
genom
rna
replic
h
treatment
nanomolar
concentr
cytotox
present
fig
similar
inhibit
observ
infect
perform
high
moi
fig
moi
furthermor
perform
timeofaddit
experi
exclud
possibl
osbp
involv
earli
step
viru
life
cycl
fig
similar
result
obtain
use
fig
anoth
establish
osbp
ligand
next
wonder
whether
endogen
osbp
present
emcv
ro
whether
local
depend
pool
gener
end
cell
infect
emcv
h
treat
dmso
min
acut
deplet
prior
immunofluoresc
analysi
noninfect
cell
osbp
cell
mockinfect
infect
gfpemcv
moi
h
pi
cell
fix
stain
antibodi
use
specif
protocol
detect
plasma
membran
intracellular
pool
describ
previous
nuclei
stain
dapi
blue
b
quantif
level
immunofluoresc
analysi
cell
mockinfect
infect
emcv
moi
h
pi
cell
fix
stain
intracellular
viral
dsrna
intens
fluoresc
signal
wholecel
zstack
quantifi
use
imagej
shown
mean
valu
sem
cell
per
condit
mean
mock
infect
cell
statist
analyz
use
mannwhitney
test
p
c
emcv
ro
contain
cell
mockinfect
infect
moi
h
pi
cell
treat
dmso
inhibitor
min
fix
stain
intracellular
ha
use
specif
antibodi
nuclei
stain
dapi
blue
crop
panel
bottom
depict
enlarg
box
area
scale
bar
repres
picornaviru
emcv
converg
host
lipid
pathway
use
hcv
local
throughout
cytoplasm
golgi
osbp
mainli
found
ro
infect
cell
larg
coloc
fig
pearson
correl
coeffici
sinc
golgi
protein
present
ro
fig
result
suggest
osbp
specif
recruit
emcv
follow
inhibit
short
treatment
observ
strong
signific
reduct
osbp
coloc
fig
pearson
coeffici
importantli
subcellular
local
osbp
noninfect
cell
affect
treatment
fig
demonstr
presenc
osbp
emcv
replic
structur
condit
given
coloc
osbp
sought
verifi
whether
emcv
respons
osbp
recruit
end
myctag
emcv
ectop
express
cell
recruit
endogen
osbp
analyz
immunofluoresc
analysi
cell
express
osbp
redistribut
punctat
structur
throughout
cytoplasm
puncta
coloc
fig
contrast
osbp
remain
local
golgi
local
puncta
fig
data
indic
emcv
infect
osbp
recruit
ro
via
test
whether
osbp
involv
transfer
cholesterol
ro
manner
cell
infect
emcv
h
treat
h
block
activ
osbp
function
respect
subject
immunofluoresc
analysi
noninfect
cell
cholesterol
mainli
local
endosom
perinuclear
area
plasma
membran
visual
filipin
stain
infect
cell
treat
dmso
detect
cholesterol
primarili
coloc
structur
pearson
coeffici
drugtreat
cell
coloc
markedli
reduc
fig
pearson
coeffici
result
confirm
emcv
ro
acquir
cholesterol
action
osbp
rna
virus
display
immens
genet
divers
yet
reli
remodel
membran
viral
genom
replic
divers
array
cellular
organel
remodel
viral
replic
structur
instanc
picornavirus
genera
enteroviru
kobuviru
thought
replic
modifi
golgi
membran
flaviviru
hcv
replic
membran
web
origin
er
virus
rewir
host
pathway
involv
lipid
synthesi
transport
gener
replic
membran
uniqu
lipid
signatur
picornavirus
genu
cardioviru
build
ro
current
unknown
identifi
osbp
essenti
host
factor
genom
replic
cardioviru
emcv
data
suggest
emcv
ro
may
deriv
er
recruit
ro
interact
viral
protein
b
recruit
led
signific
increas
intracellular
level
infect
cell
prove
import
downstream
recruit
osbp
final
data
present
suggest
osbpmedi
exchang
cholesterol
romcss
critic
emcv
genom
replic
global
organ
ro
membran
alter
cytoplasm
cardiovirusinfect
cell
alreadi
observ
decad
ago
electron
microscopi
also
describ
enterovirus
cardiovirusinduc
membran
consist
perinuclear
cluster
heterogen
singleand
doublemembran
vesicl
dmv
recent
studi
greatli
contribut
understand
origin
biogenesi
enteroviru
ro
cardiovirus
detail
remain
scarc
report
zhang
et
al
propos
emcv
subvert
autophagi
pathway
promot
viru
replic
ro
format
author
observ
induct
autophagi
accumul
cytoplasm
doublemembran
vesicl
dmv
hallmark
autophagosom
upon
emcv
infect
howev
inhibit
autophagi
stronger
effect
extracellular
intracellular
viru
yield
point
toward
role
autophagi
viru
releas
inde
recent
studi
use
enterovirus
flavivirus
support
hypothesi
autophagyderiv
membran
rather
serv
mean
nonlyt
viru
releas
spread
membran
sourc
viral
ro
oppos
enterovirus
member
cardioviru
genu
insensit
deplet
sirna
treatment
bfa
compound
target
subsequ
block
activ
key
regul
membran
traffick
secretori
picornaviru
emcv
converg
host
lipid
pathway
use
hcv
pathway
furthermor
cardioviru
replic
requir
golgiloc
essenti
enteroviru
replic
collect
data
suggest
cardiovirus
reli
golgi
compon
replic
line
previou
find
present
data
suggest
emcv
may
deriv
ro
er
membran
confoc
microscopi
analysi
reveal
emcv
nonstructur
protein
partial
overlap
er
marker
calreticulin
marker
ere
ergic
cisor
transgolgi
network
appear
dispers
infect
cell
even
earliest
stage
infect
furthermor
normal
resid
er
network
redistribut
emcvinfect
cell
discret
cytoplasm
structur
also
contain
viral
protein
interestingli
major
puncta
detect
close
proxim
viral
dsrna
complet
overlap
dsrna
suggest
spatial
segreg
dsrna
viral
replic
membran
previous
also
shown
coronavirus
use
pharmacolog
inhibitor
prove
emcv
safv
belong
distinct
cardioviru
speci
requir
lipid
kinas
activ
replic
agreement
result
observ
elev
level
intracellular
membran
infect
cell
suggest
import
role
lipid
cardioviru
replic
noninfect
cell
osbp
play
critic
role
lipid
homeostasi
exchang
cholesterol
interfac
er
golgi
membran
local
normal
condit
process
lipid
also
serv
membran
anchor
osbp
hypothes
cardioviru
infect
may
serv
recruit
osbp
cholesterol
viral
replic
site
inde
osbp
present
emcv
ro
coloc
viral
protein
coloc
markedli
reduc
upon
treatment
demonstr
osbp
recruit
osbp
essenti
cardioviru
host
factor
sinc
genet
deplet
sirna
treatment
pharmacolog
inhibit
block
viral
genom
replic
cholesterol
redistribut
emcv
ro
upon
infect
treatment
result
significantli
reduc
coloc
cholesterol
argu
accumul
cholesterol
ro
mediat
osbp
data
agreement
recent
find
cholesterol
shuttl
import
cardioviru
genom
replic
cardiovirus
sensit
itraconazol
recent
discov
inhibitor
osbp
result
indic
cholesterol
vital
global
organ
emcv
ro
howev
lipid
fulfil
multipl
function
variou
cellular
process
role
viru
replic
envisag
potenti
task
viru
replic
may
link
pi
p
synthesi
pathway
sinc
major
precursor
pi
p
lipid
recent
attribut
import
role
hcv
replic
cholesterol
homeostasi
recent
shown
play
import
role
effici
pv
polyprotein
process
whether
cholesterol
also
ensur
proper
microenviron
support
cardioviru
polyprotein
process
remain
determin
interestingli
appar
parallel
distantli
relat
enterovirus
exploit
pathway
hcv
correl
induct
membran
posit
curvatur
contrast
flaviviru
denv
although
close
relat
hcv
requir
osbp
gener
membran
neg
curvatur
henc
interplay
cholesterol
may
dictat
posit
curvatur
membran
divers
rna
virus
replic
genom
coip
assay
identifi
novel
interact
partner
emcv
protein
precursor
emcv
small
protein
amino
acid
unknown
structur
contain
predict
hydrophob
domain
cterminu
half
express
alon
suffici
recruit
intact
cell
argu
infect
recruit
ro
viral
protein
enterovirus
kobuvirus
recruit
ro
also
via
protein
rais
possibl
divers
picornavirus
might
use
evolutionari
conserv
mechan
gener
membran
howev
protein
entero
kobuand
cardiovirus
share
appar
sequenc
similar
name
simpli
reflect
occup
locu
respect
viral
genom
except
catalyt
domain
also
isoform
share
sequenc
similar
furthermor
unlik
enterovirus
cardioviru
interact
block
protein
transport
secretori
pathway
express
alon
highlight
function
diversif
associ
small
viral
protein
emcv
hcv
converg
recruit
common
lipidmodifi
pathway
build
replic
site
sever
line
evid
suggest
picornaviru
emcv
distantli
relat
flaviviru
hcv
evolv
exploit
common
host
compon
assist
viru
rna
replic
first
hcv
genom
replic
occur
membran
web
mw
network
singl
dmv
like
emcv
ro
also
mainli
origin
er
second
emcv
hcv
express
viral
protein
dedic
recruit
order
induc
environ
replic
site
third
hcv
infect
lipid
also
shown
import
recruit
osbp
mediat
cholesterol
transfer
mw
fourth
inhibit
either
osbp
induc
clear
alter
global
distribut
emcv
ro
appear
cluster
upon
treatment
similar
cluster
effect
also
observ
replic
structur
hcv
mw
upon
osbp
inhibit
wherea
obviou
disrupt
enteroviru
ro
observ
upon
osbp
inhibit
togeth
observ
indic
emcv
hcv
replic
structur
share
critic
host
compon
possibl
also
similar
architectur
although
latter
still
remain
determin
base
least
two
line
emerg
evid
context
phylogeni
flaviand
picornavirus
emcv
hcv
like
converg
rather
retain
function
similar
upon
diverg
common
ancestor
fig
first
observ
common
emcv
hcv
share
character
virus
respect
famili
indic
manifest
properti
conserv
among
two
famili
instanc
picornavirus
differ
genera
exhibit
differ
host
factor
requir
member
cardioviru
genu
hijack
erloc
studi
wherea
member
enteroviru
kobuviru
genera
depend
golgiloc
contrast
equin
rhiniti
viru
erav
member
aphthoviru
genu
prototyp
fmdv
hepat
viru
hepatoviru
genu
seem
replic
independ
fig
likewis
flavivirus
denv
wnv
repres
sister
genu
hcv
reli
either
denv
also
shown
requir
osbp
wnv
known
yet
importantli
cardiovirus
target
occupi
lineag
farther
root
compar
enteroand
kobuvirus
target
fig
phylogenet
pattern
indic
rel
recent
emerg
emcvspecif
target
properti
second
emcv
hcv
employ
appar
unrel
protein
mediat
interact
name
although
hcv
may
contribut
well
protein
membranebound
albeit
hydrophob
domain
locat
either
nterminu
cterminushalf
includ
anoth
region
among
least
conserv
nonstructur
protein
respect
famili
studi
contribut
hypothesi
virus
may
confront
power
constraint
limit
divers
host
pathway
recruit
effici
replic
thu
common
pathway
use
differ
rna
virus
either
moder
diverg
eg
differ
speci
genu
converg
host
target
diverg
profoundli
differ
familieseg
emcv
hcv
date
small
number
rna
virus
studi
term
host
lipid
requir
identif
lipid
pathway
use
virus
hope
provid
deeper
insight
constraint
virus
confront
endeavor
replic
genom
buffalo
green
monkey
bgm
kidney
cell
babi
hamster
kidney
hela
cell
grown
co
dulbecco
modifi
eagl
medium
dmem
lonza
supplement
fetal
bovin
serum
fb
cell
provid
r
bartenschlag
depart
molecular
virolog
univers
heidelberg
heidelberg
germani
grown
dmem
lonza
supplement
fb
blasticidin
paa
bgm
cell
purchas
ecacc
cell
purchas
atcc
hela
cell
obtain
g
belov
univers
maryland
virginiamaryland
region
colleg
veterinari
medicin
us
kind
gift
j
neyt
rega
institut
medic
research
univers
leuven
leuven
belgium
md
shair
depart
chemistri
chemic
biolog
harvard
univers
cambridg
usa
respect
purchas
santa
cruz
provid
galapago
nv
filipin
iii
dipyridamol
sigma
entir
tree
root
accord
gibrat
et
al
addit
also
suggest
involv
interact
picornaviru
emcv
converg
host
lipid
pathway
use
hcv
plasmid
construct
provid
g
hammond
nichd
nation
institut
health
bethesda
usa
myc
describ
previous
kind
gift
n
altanbonnet
laboratori
hostpathogen
dynam
nation
institut
health
bethesda
usa
gener
ctermin
myctag
emcv
protein
gene
encod
emcv
nonstructur
protein
amplifi
pcr
use
plasmid
primer
introduc
restrict
site
bamhi
hindiii
contain
fulllength
infecti
cdna
sequenc
emcv
strain
mengoviru
pcr
product
clone
myc
backbon
gene
remov
use
restrict
enzym
allow
ectop
express
cmv
promot
gene
encod
amplifi
pcr
use
templat
introduc
backbon
use
restrict
enzym
sali
noti
infecti
clone
gener
introduc
ha
code
sequenc
ypydvpdya
infram
codon
use
mutagenesi
primer
sitedirect
mutagenesi
kit
new
england
biolab
emcv
rlucemcv
contain
renilla
luciferas
gene
upstream
capsid
code
region
obtain
transfect
cell
rna
transcript
deriv
full
length
infecti
clone
respect
linear
bamhi
gfpemcv
contain
egfp
gene
upstream
capsid
region
gener
similar
rlucemcv
strain
nanci
obtain
transfect
bgm
cell
rna
transcript
full
length
infecti
clone
linear
sali
saffold
viru
type
describ
previous
erav
kindli
provid
david
rowland
tobi
tuthil
univers
leed
unit
kingdom
viru
infect
perform
incub
subconflu
cell
monolay
min
viru
viruscontain
medium
remov
fresh
compoundcontain
medium
ad
cell
timeofaddit
experi
medium
without
compound
ad
replac
medium
compound
indic
time
point
given
time
point
post
infect
cell
either
fix
immunolabel
freezethaw
determin
viru
titer
case
rlucemcv
lyse
determin
replic
measur
intracellular
renilla
luciferas
activ
use
renilla
luciferas
assay
system
promega
viru
titer
determin
endpoint
titrat
accord
method
reed
muench
express
tissu
cultur
infect
dose
hela
cell
grown
subconflu
coverslip
plate
indic
cell
transfect
ng
plasmid
use
accord
manufactur
protocol
andor
infect
emcv
specifi
multipl
infect
moi
follow
compound
treatment
specifi
indic
time
point
cell
fix
paraformaldehyd
pfa
min
room
temperatur
rt
permeabil
done
triton
min
bsa
min
case
filipin
stain
cell
incub
sequenti
primari
secondari
antibodi
dilut
pb
contain
normal
goat
serum
ng
follow
primari
antibodi
use
detect
mous
monoclon
bd
bioscienc
rabbit
polyclon
novu
biolog
mous
monoclon
enzo
life
scienc
rabbit
polyclon
kindli
provid
bl
tang
depart
biochemistri
nation
univers
singapor
singapor
rabbit
polyclon
anticalreticulin
sigma
rabbit
polyclon
antiha
santa
cruz
mous
monoclon
antiha
abcam
mous
monoclon
anticmyc
sigma
rabbit
polyclon
antimyc
thermo
scientif
mous
igm
echelon
bioscienc
mous
monoclon
antidsrna
english
scientif
consult
mous
monoclon
antiemcv
kind
gift
ag
aminev
rabbit
polyclon
antiosbp
kindli
provid
de
mattei
telethon
institut
genet
medicin
napl
itali
alexa
fluor
igg
alexa
fluor
igm
invitrogen
molecular
probe
use
secondari
antibodi
cholesterol
stain
filipin
iii
sigma
h
room
temperatur
includ
incub
secondari
antibodi
nuclei
counterstain
dapi
stain
plasma
membran
intracellular
perform
describ
elsewher
briefli
pm
stain
cell
fix
rt
pfa
glutaraldehyd
subsequ
step
perform
ice
cell
block
permeabil
min
buffer
pipe
ph
mm
nacl
mm
kcl
contain
ng
mm
nh
cl
saponin
slide
incub
primari
secondari
antibodi
buffer
contain
ng
saponin
h
final
slide
postfix
pfa
pb
min
intracellular
stain
perform
rt
follow
cell
fix
pfa
permeabil
min
digitonin
buffer
block
min
buffer
ng
mm
nh
cl
incub
sequenti
primari
secondari
antibodi
buffer
ng
post
fixat
pfa
coverslip
mount
fluorsav
calbiochem
imag
acquir
leica
speii
confoc
laser
scan
microscop
nikon
ti
eclips
microscop
equip
andor
emccdcamera
quantif
perform
least
cell
condit
use
imagej
softwar
describ
elsewher
determin
coloc
calreticulin
imag
first
deconvolut
use
ni
advanc
research
softwar
nikon
iter
process
use
imag
j
follow
individu
infect
cell
outlin
mask
creat
signal
outsid
mask
crop
exclud
calcul
mander
coloc
coeffici
calcul
least
cell
condit
use
jacop
plugin
manual
set
threshold
coloc
osbp
infect
cell
analyz
use
imagej
determin
pearson
coeffici
least
cell
per
condit
use
coloc
plugin
default
set
quantifi
coloc
filipin
imag
first
deconvolut
use
ni
softwar
iter
imagej
use
select
infect
cell
pearson
coeffici
coloc
least
cell
per
condit
calcul
use
coloc
plugin
default
set
hela
cell
reversetransfect
pmole
sirna
per
well
plate
cellswel
use
lipofectamin
invitrogen
accord
manufactur
indic
scrambl
sirna
allstar
neg
control
qiagen
use
control
sirna
cat
target
sequenc
qiagen
sirna
hosbp
two
sirna
mix
ratio
cell
viabil
determin
parallel
viru
infect
follow
one
day
seed
cell
plate
compound
ad
cell
incub
h
altern
cell
transfect
sirna
incub
h
subsequ
medium
replac
celltit
aqueou
one
solut
reagent
promega
optic
densiti
measur
nm
obtain
raw
valu
convert
percentag
untreat
sampl
sampl
transfect
scrambl
sirna
follow
correct
background
absorb
metabol
label
myctag
emcv
protein
perform
describ
elsewher
briefli
cell
seed
plate
cotransfect
plasmid
encod
emcv
nonstructur
protein
either
ptm
empti
ptm
vector
mock
use
invitrogen
accord
manufactur
instruct
h
later
cell
starv
methioninecysteinefre
medium
h
radiolabel
cell
done
overnight
incub
methioninecysteinefre
medium
supplement
mm
glutamin
mm
hepe
express
protein
label
mix
perkin
elmer
boston
cell
harvest
lyse
lysi
buffer
mm
triscl
ph
mm
nacl
nonidet
proteas
inhibitor
h
ice
follow
centrifug
g
min
supernat
subject
immunoprecipit
h
incub
anticmyc
rabbit
polyclon
antibodi
santa
cruz
immunocomplex
captur
protein
gsepharos
bead
sigma
addit
h
incub
bead
wash
three
time
lysi
buffer
follow
elut
immunocomplex
boil
sampl
buffer
separ
polyacrylamidesd
gel
electrophoresi
detect
autoradiographi
coip
follow
western
blot
cell
seed
cm
dish
transfect
plasmid
use
polyethylenimin
pei
polysci
immunoprecipit
carri
describ
use
protein
asepharos
bead
ge
healthcar
mous
monoclon
anticmyc
sigma
rabbit
polyclon
antimyc
thermo
scientif
antibodi
sampl
separ
sdspage
transfer
nitrocellulos
membran
biorad
membran
incub
follow
primari
antibodi
rabbit
polyclon
cell
signal
rabbit
polyclon
upstat
rabbit
polyclon
antiosbp
proteintech
rabbit
polyclon
antiemcv
capsid
kind
gift
ann
palmenberg
mous
monoclon
sigma
secondari
antibodi
includ
irdy
goat
antimous
irdy
goat
antirabbit
licor
imag
blot
acquir
odyssey
fc
imag
system
licor
indic
unpair
onetail
student
ttest
twotail
mannwhitney
test
appli
statist
analys
use
graphpad
prism
softwar
support
inform
fig
inhibit
emcv
step
genom
replic
effect
emcv
also
high
moi
hela
cell
infect
rlucemcv
moi
follow
treatment
h
cell
lyse
viru
replic
measur
determin
renilla
luciferas
activ
b
block
emcv
genom
replic
hela
cell
infect
rlucemcv
moi
indic
time
point
dmso
dipyridamol
ad
cell
viru
replic
measur
determin
renilla
luciferas
activ
h
pi
bar
repres
mean
valu
triplic
standard
error
mean
sem
mean
statist
compar
use
unpair
test
hela
cell
mockinfect
infect
gfpemcv
moi
h
pi
cell
fix
stain
antibodi
use
specif
protocol
detect
plasma
membran
intracellular
pool
nuclei
stain
dapi
blue
scale
bar
repres
